Multiple mechanisms of immune evasion by African trypanosomes

Molecular and Biochemical Parasitology

Volumn 91, Issue 1, 1998, Pages

  Donelson, John E ^a   Hill, Kent L ^a   El Sayed, Najib M A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Leishmania; Recombinant; T cell; Trypanosomes; VSG genes

Indexed keywords

COMPLEMENT; GAMMA INTERFERON; VARIANT SURFACE GLYCOPROTEIN;

AFRICAN TRYPANOSOMIASIS; AMINO ACID SEQUENCE; ANTIGENIC VARIATION; GENE EXPRESSION; HOST PARASITE INTERACTION; IMMUNE RESPONSE; LEISHMANIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TSETSE FLY;

LEISHMANIA;

EID: 0032029346     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(97)00209-0     Document Type: Article

References (70)

1. [1] Ross R, Thomson D. A case of sleeping sickness studied by precise enumerative methods: further observations. Proc R Soc London 1910;83:187-205.
2. [2] Bridgen PJ, Cross GAM, Bridgen J. N-terminal amino acid sequences of variant-specific surface antigens from Trypanosoma brucei. Nature 1976;263:613-4.
3. [3] Williams RO, Young JR, Majiwa PAO. Genomic rearrangements correlated with antigenic variation in in Trypanosoma brucei. Nature 1979;282:847-9.
4. [4] Hoeijmakers JH, Frasch AC, Bernards A, Borst P, Cross GA. Novel expression-linked copies of the genes for variant surface antigen in trypanosomes. Nature 1980;284:78-80.
5. [5] Vickerman K. Developmental cycles and biology of pathogenic trypanosomes. Br Med Bull 1985;41:105-14.
6. [6] Sileghem M, Flynn JN, Darji A, De Baetselier P, Naessens J. African Trypanosomiasis. In: Kierszenbaum F, editor. Parasite Infections and the Immune System. San Diego: Academic Press, 1994:1-51.
7. [7] Urquhart GM, Murray M, Murray PK, Jennings FW, Bate E. Immunosuppression in Trypanosoma brucei infections in rates and mice. Trans R Soc Trop Med Hyg 1973;67:528-35.
8. [8] Diffley P. Trypanosomal surface coat variant antigen causes polyclonal lymphocyte activation. J Immunol 1983;131:1983-6.
9. [9] Jokiranta TS, Jokipii L, Meri S. Complement resistance of parasites. Scand J Immunol 1995;42:9-20.
10. [10] Dempsey WA, Mansfield JM. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J Immunol 1983;130:405-11.
11. [11] Esser KM, Schoenbechler MJ, Gingrich JB. Trypanosoma rhodesiense blood forms express all antigen specificities relevant to protection against metacyclic (insect form) challenge. J Immunol 1982;129:1715-8.
12. [12] Crowe JS, Barry JD, Luckins AG, Ross CA, Vickerman K. All metacyclic variable antigen types of Trypanosoma congolense identified using monoclonal antibodies. Nature 1983;306:389-91.
13. [13] Turner CM, Barry JD, Maudlin I, Vickerman K. An estimate of the size of the metacyclic variable antigen repertoire of Trypanosoma brucei rhodesiense. Parasitology 1988;97:269-76.
14. [14] Alarcon CM, Son HJ, Hall T, Donelson JE. A monocistronic transcript for a trypanosome variant surface glycoprotein. Mol Cell Biol 1994;14:5579-91.
15. [15] Graham SV, Barry JD. Transcriptional regulation of metacyclic variant surface glycoprotein gene expression during the life cycle of Trypanosoma brucei. Mol Cell Biol 1995;15:5945-56.
16. [16] Lu Y, Hall T, Gay LS, Donelson JE. Point mutations are associated with a gene duplication leading to the bloodstream reexpression of a trypanosome metacyclic VSG. Cell 1993;72:397-406.
17. [17] McCulloch R, Rudenko G, Borst P. Gene conversions mediating antigenic variation in Trypanosoma brucei can occur in variant surface glycoprotein expression sites lacking 70-base-pair repeat sequences. Mol Cell Biol 1997;17:833-43.
18. [18] Nagoshi Lu Y, Alarcon CM, Donelson JE. The putative promoter for a metacyclic VSG gene in African trypanosomes. Mol Biochem Parasitol 1995;72:33-45.
19. [19] Kim KS, Donelson JE. Co-duplication of a variant surface glycoprotein gene and its promoter to an expression site in African trypanosomes. J Biol Chem 1997;272:24637-45.
20. [20] Pays E, Coquelet H, Tebabi P, Pays A, Jefferies D, Steinert M, Koenig E, Williams RO, Roditi I. Trypanosoma brucei: constitutive activity of the VSG and procyclin gene promoters. EMBO J 1990;9:3145-51.
21. [21] Gottesdiener K, Chung H-M, Brown SD, Lee MG-S, Van der Ploeg LHT. Characterization of VSG gene expression site promoters and promoter-associated DNA rearrangement events. Mol Cell Biol 1991;11:2467-80.
22. [22] Zomerdijk JCBM, Kieft R, Shiels PG, Borst P. Alpha-amanitin-resistant transcription units in trypanosomes: a comparison of promoter sequences for a VSG gene expression site and for the ribosomal RNA genes. Nucleic Acids Res 1991;19:5153-8.
23. [23] Lu Y, Alarcon CM, Hall T, Reddy LV, Donelson JE. A strand bias occurs in point mutations associated with VSG gene conversion in Trypanosoma rhodesiense. Mol Cell Biol 1994;14:3971-80.
24. [24] Donelson JE. Mechanisms of antigenic variation in Borrelia hermsii and African trypanosomes. J Biol Chem 1995;270:7783-6.
25. [25] Kimmel BE, Ole-MoiYoi OK, Young JR. Ingi, a 5.2 kb dispersed sequence element from Trypanosoma brucei that carries half of a smaller mobile element at either end and has homology with mammalian lines. Mol Cell Biol 1987;7:1465-75.
26. [26] Lodes MJ, Smiley BL, Stadnyk AW, Bennett JL, Myler PJ, Stuart K. Expression of a retroposon-like sequence upstream of the putative Trypanosoma brucei variant surface glycoprotein gene expression site promoter. Mol Cell Biol 1993;13:7036-44.
27. [27] Aksoy S, Lalor TM, Martin J, Van der Ploeg LH, Richards FF. Multiple copies of a retroposon interrupt spliced leader RNA genes in the African trypanosome, Trypanosoma gambiense. EMBO J 1987;6:3819-26.
28. [28] Pays E, Murphy NB. DNA-binding fingers encoded by a trypanosome retroposon. J Mol Biol 1987;197:147-8.
29. [29] Morgan RW, El-Sayed NMA, Kepa JK, Pedram M, Donelson JE. Differential expression of the expression site-associated gene I family in African trypanosomes. J Biol Chem 1996;271:9771-7.
30. [30] Olsson T, Bakhiet M, Hojeberg B, Ljungdahl A, Edlund C, Andersson G, Ekre H-P, Fung-Leung W-P, Mak T, Wigzell H, Fiszer U, Kristensson K. CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 1993;72:715-27.
31. + T cells suppresses growth of Trypanosoma brucei brucei and interferon-gamma production in infected rats. Clin Exp Immunol 1990;81:195-9.
32. + T cells. Parasitol Today 1992;8:237-9.
33. + T cells: a trypanosome-released factor triggers interferon-γ production that stimulates parasite growth. Eur J Immunol 1991;21:2447-54.
34. [34] Hua SB, Wang CC. Interferon-gamma activation of a mitogen-activated protein kinase, KFR1, in the blood-stream form of Trypanosoma brucei. J Biol Chem 1997;272:10797-803.
35. + lymphocytes to interferon-γ secretion: Purification, characterization and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand J Immunol 1993;37:165-78.
36. [36] Bakhiet M, Olsson T, Mhlanga J, Buscher P, Lycke N, Van der Meide PH, Kristensson K. Human and rodent interferon-γ as a growth factor for Trypanosoma brucei. Eur J Immunol 1996;26:1359-64.
37. [37] Vaidya T, Bakhiet M, Hill KL, Olsson T, Kristensson K, Donelson JE. The gene for a trypanosome triggering factor from African trypanosomes. J Exp Med 1997;186:433-8.
38. [38] Okamura H, Tsutsul H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
39. [39] McKerrow JH. The proteases and pathogenicity of parasitic protozoa. Annu Rev Microbiol 1993;47:821-53.
40. [40] Lonsdale-Eccles JD, Mpimbaza WN, Nkhungulu RM, Olobo J, Smith L, Tosomba OM, Grab DJ. Trypanosomatid cysteine protease activity may be enhanced by a kininogen-like moiety from host serum. Biochem J 1995;305:549-56.
41. [41] Kapur V, Majesky MW, Li L-L, Black RA, Musser JM. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1b by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 1993;90:7676-80.
42. [42] LaMarre J, Wollenberg GK, Gonias SL, Hayes MA. Cytokine binding and clearance properties of proteinase-activated α2-macroglobulins. Lab Invest 1991;65:3-14.
43. [43] Schatz G, Dobberstein B. Common principles of protein translocation across membranes. Science 1996;271:1519-26.
44. [44] Hug M, Carruthers VB, Hartmann C, Sherman DS, Cross GAM, Clayton C. A possible role for the 3′-untranslated region in developmental regulation in Trypanosoma brucei. Mol Biochem Parasitol 1993;61:87-96.
45. [45] Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996;173:33-8.
46. [46] Muesch A, Hartmann E, Rohde K, Rubartelli A, Sitia R, Rapoport TA. A novel pathway for secretory proteins? TIBS 1990;15:86-8.
47. [47] Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 1989;8:757-64.
48. [48] El-Sayed NMA, Donelson JE. A survey of Trypanosoma brucei rhodesiense genome using shotgun sequencing. Mol Biochem Parasitol 1997;84:167-78.
49. [49] Bordier C. The promastigote surface protease of Leishmania. Parasitol Today 1987;3:151-3.
50. [50] Bouvier J, Schneider P, Etges R. Leishmanolysin: Surface metalloproteinase of Leishmania. Methods Enzymol 1995;248:614-33.
51. [51] Chang K-P, Chaudhuri G. Molecular determinants of Leishmania virulence. Annu Rev Microbiol 1990;44:499-529.
52. [52] Roberts SC, Swihart KG, Agey MW, Ramamoorthy R, Wilson ME, Donelson JE. Sequence diversity and organization of the msp gene family encoding gp63 of Leishmania chagasi. Mol Biochem Parasitol 1993;62:157-72.
53. [53] Medina-Acosta E, Beverley SM, Russell DG. Evolution and expression of the Leishmania surface proteinase (gp63) gene locus. Infect Agents Dis 1993;2:25-34.
54. [54] Chang C-S, Chang K-P. Monoclonal antibody affinity purification of a leishmania membrane glycoprotein and its inhibition of Leishmania-macrophage binding. Proc Natl Acad Sci USA 1986;83:100-4.
55. [55] Liu X, Chang K-P. Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages. Proc Natl Acad Sci USA 1992;89:4991-5.
56. [56] Soteriadou KP, Remoundos MS, Katsikas MD, Tzinia AK, Tsikaris V, Sakarellos D, Tzartos SJ. The Ser-Arg-Tyr-Asp region of the major surface glycoprotein of Leishmania minies the Arg-Gly-Asp-Ser cell attachment region of fibronectin. J Biol Chem 1992;267:13980-5.
57. [57] McGwire B, Chang K-P. Genetic rescue of surface metalloproteinase (gp63)-deficiency in Leishmania amazonensis variants increases their infection of macrophages at the early phase. Mol Biochem Parasitol 1994;66:345-7.
58. [58] Brittingham A, Morrison CJ, McMaster WR, McGwire BS, Chang K-P, Mosser DM. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol 1995;155:3102-11.
59. [59] Olobo JO, Anjili CO, Gicheru MM, Mbati PA, Kariuki TM, Githure JI, Koech DK, McMaster WR. Vaccination of vervet monkeys against cutaneous leishmaniosis using recombinant Leishmania'major surface glycoprotein' (gp63). Vet Parasitol 1995;60:199-212.
60. [60] Gheorghiu M, Dellagi K, Gicquel B. Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice. Microbiology 1995;141(Pt 7):1585-92.
61. [61] Xu D, McSorley SJ, Chatfield SN, Dougan G, Liew FY. Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA-AroD-). Immunology 1995;85:1-7.
62. [62] Connell ND, Medina-Acosta E, McMaster WR, Bloom B, Russell DG. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci USA 1993;90:11473-7.
63. [63] Inverso JA, Medina-Acosta E, O'Connor J, Russell DG, Cross GAM. Crithidia fasciculata contains a transcribed leishmanial surface proteinase (gp63) gene homologue. Mol Biochem Parasitol 1993;57:47-54.
64. [64] McGwire BS, Chang K-P. Posttranslational regulation of a Leishmania HEXXH metalloprotease (gp63). J Biol Chem 1996;271:7903-9.
65. [65] Devine DV, Falk RJ, Balber AE. Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense. Infect Immun 1986;52:223-9.
66. [66] Mosser DM, Roberts JF. Trypanosoma brucei: Recognition in vitro of two developmental forms by murine macrophages. Exp Parasitol 1982;54:310-6.
67. [67] Salles JM, Thomas N, Carreira Fragoso MA, Goldenberg S. Purification of a metalloproteinase constitutivelly expressed during Trypanosoma cruzi metacyclogenesis. Mem Inst Oswaldo Cruz 1996;91:269.
68. [68] Ramamoorthy R, Donelson JE, Maybodi M, Panitz S, Paetz KE, Wilson ME. Three distinct RNA species code for the major surface protease (gp63) of Leishmania donovani chagasi. J Biol Chem 1992;267:1888-95.
69. [69] Pepin J, Donelson JE. Human African trypanosomiasis. In: Guerrant RL, Krogstad DJ, Maguire JH, Walker KH, Weller P, editors. Tropical Infectious Diseases: Principles, Pathogens and Practice. New York: Churchill Livingstone (in press)
70. [70] El-Sayed NMA, Donelson JE. African trypanosomes have differentially expressed genes encoding homologues of the Leishmania GP63 surface protease. J Biol Chem 1997;272:26742-8.